| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/25/2003 | CN1425775A Tuberculosis antibody gold label test strip and its preparing method |
| 06/25/2003 | CN1425772A Novel plant DNA virus carrier and its use |
| 06/25/2003 | CN1425770A Plant cytoplasmic male sterile recovering gene and its use |
| 06/25/2003 | CN1425768A Polypeptide-beta lactamase-9.02 and polynucleotide for encoding such polypeptide |
| 06/25/2003 | CN1425767A Polypeptide-protein-8.91 containing indole-3-glycero phosphate synthetase structure domain and polynucleotide for encoding such polypeptide |
| 06/25/2003 | CN1425766A Polypeptide-human protein-9.24 containing basic phospatase active site and polynucleotide for encoding such polypeptide |
| 06/25/2003 | CN1425765A Polypeptide-pterin molybdenum oxido-reductase-8.91 and polynucleotide for encoding such polypeptide |
| 06/25/2003 | CN1425759A Quick detecting method for vibrio amount |
| 06/25/2003 | CN1425758A Quick detector for vibrio amount |
| 06/25/2003 | CN1112448C Fast color-changing liquid culture medium for branching bacilus and identifying method of branching bacilus and medicine sensitivity and MIC measuring method of branch bacilus |
| 06/25/2003 | CN1112447C Cell structure detecting method |
| 06/24/2003 | US6584410 Polymorphism detection utilizing clustering analysis |
| 06/24/2003 | US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection |
| 06/24/2003 | US6583279 Oligonucleotides for use in the detection of hepatitis viral sequences |
| 06/24/2003 | US6583278 Nucleic acid probes complementary to human papilloma virus nucleic acid |
| 06/24/2003 | US6583275 Nucleotide sequences coding polypeptied for use in the treatment, diagnosis and prevention of bacterial infection |
| 06/24/2003 | US6583168 Sulfonated diarylrhodamine dyes |
| 06/24/2003 | US6583167 Methods and kits for treating and diagnosing leiomyomas |
| 06/24/2003 | US6583122 Use in boron neutron capture therapy (BNCT) and diagnostic purposes; treating cancer, viral infections such as HIV, hepatitis B virus |
| 06/24/2003 | US6583112 Gene products related to werner's syndrome |
| 06/24/2003 | US6582969 Monitor binding activity of biopolymers; prepare sample, insert into multicompartment detection apparatus, incubate fluid with solid support joined to biopolymer, monitor activity between biopolymers joined to support and fluid |
| 06/24/2003 | US6582954 Apparatus for use in the detection of preferential particle in biological sample |
| 06/24/2003 | US6582938 Amplification of nucleic acids |
| 06/24/2003 | US6582936 Generation of preferential nucleotide sequences; obtain single stranded nucleotide sequences, incubate with polymerase, primers and reaction mixture, amplify and recover nucleotide sequences |
| 06/24/2003 | US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof |
| 06/24/2003 | US6582929 Method for minimizing optical interference during antibiotic susceptibility readings in a microbiological analyzer |
| 06/24/2003 | US6582927 Method for detecting protein-protein interactions and a kit therefor |
| 06/24/2003 | US6582925 Desaturase antigen of mycobacterium tuberculosis |
| 06/24/2003 | US6582923 Method for analyzing polynucleotides |
| 06/24/2003 | US6582922 Kit for use in the extraction of nucleotide sequences from sample |
| 06/24/2003 | US6582921 Detecting preferential nucleotide sequences in sample; obtain sample incubate with probe, detect signal |
| 06/24/2003 | US6582920 Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
| 06/24/2003 | US6582919 Obtaining a tissue sample of the tumor and non-malignant tissue; isolating mRNA; amplification using primers; determining the amount of HER2-neu mRNA; obtaining a differential HER2-neu epression level; determining |
| 06/24/2003 | US6582918 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 06/24/2003 | US6582917 Method for controlling quality in the construction of oligomer grids |
| 06/24/2003 | US6582916 Compound for use as diagnostic tools in mass spectrometry |
| 06/24/2003 | US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences |
| 06/24/2003 | US6582911 Candida albicans KRE9 and uses thereof |
| 06/24/2003 | US6582910 WbpP and method for assay of WbpP |
| 06/24/2003 | US6582909 Genotyping biological sample; obtain sample, extract nucleotide sequence, sequence, compare to control, detect adjustments in sequences, score |
| 06/24/2003 | US6582908 Oligonucleotides |
| 06/24/2003 | US6582907 Detection of binding agent in sample; obtain sample containing binding agent, denature, detect denaturation signal, monitor denaturation signal of targget species |
| 06/24/2003 | US6582906 Proportional amplification of nucleic acids |
| 06/24/2003 | US6582904 Method of quantifying tumour cells in a body fluid and a suitable test kit |
| 06/24/2003 | US6582903 Method and a device for the evaluation of biopolymer fitness |
| 06/24/2003 | US6582902 Method for deriving epitopes |
| 06/24/2003 | US6582901 Cell specific anti-viral drug susceptibility test using tagged permissive target cells |
| 06/24/2003 | US6582900 Methods of the invention are useful for the identification of herbicides and other compounds that can modulate plant growth and development |
| 06/24/2003 | US6582899 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 06/24/2003 | US6582703 Medical diagnosis; amplification primers; genetic engineering |
| 06/24/2003 | US6582662 Devices and methods for the performance of miniaturized homogeneous assays |
| 06/24/2003 | US6582660 Control system for active programmable electronic microbiology system |
| 06/24/2003 | US6582583 Amperometric biomimetic enzyme sensors based on modified cyclodextrin as electrocatalysts |
| 06/24/2003 | US6582573 Membrane based electrochemical test device |
| 06/24/2003 | US6581391 Ice thickness control system and sensor probe |
| 06/24/2003 | CA2087033C Fibrinogen assays using dry chemical reagents containing magnetic particles |
| 06/24/2003 | CA2076210C Assay for serum cholinesterase activity |
| 06/24/2003 | CA2012311C New protein-polycation-conjugate |
| 06/22/2003 | CA2412226A1 Compositions, methods and systems for discovery of lipopeptides |
| 06/21/2003 | CA2412187A1 Assay for identifying modulators of borrelia telomere resolvase |
| 06/19/2003 | WO2003050531A2 Method for displaying loops from immunoglobulin domains in different contexts |
| 06/19/2003 | WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 06/19/2003 | WO2003050500A1 Early diagnosis of cancer or precancerous conditions by leakage of signature peptides and carbohydrates into the bloodstream |
| 06/19/2003 | WO2003050312A1 Methods for determining transcriptional activity |
| 06/19/2003 | WO2003050311A2 Methods and compositions for diagnosing and treating hypotrichosis simplex |
| 06/19/2003 | WO2003050310A2 Methods for the identification of inhibitors of asparagine synthase, 5-aminolevulinate synthase, histidinol-phosphatase, 3-isopropylmalate and threonine synthase as antibiotics |
| 06/19/2003 | WO2003050308A1 Highly-sensitive genomic assays employing chimeric bacteriophage standards |
| 06/19/2003 | WO2003050307A1 Compounds for therapy and diagnosis and methods for using same |
| 06/19/2003 | WO2003050306A1 Hybridization portion control oligonucleotide and its uses |
| 06/19/2003 | WO2003050305A1 Annealing control primer and its uses |
| 06/19/2003 | WO2003050304A1 Annealing control primer system for regulating primer annealing specificity and its applications |
| 06/19/2003 | WO2003050303A2 Biallelic markers of d-amino acid oxidase and uses thereof |
| 06/19/2003 | WO2003050302A2 Tgnp activity or expression as marker for apoptosis |
| 06/19/2003 | WO2003050301A2 Susceptibility locus for schizophrenia |
| 06/19/2003 | WO2003050300A2 Diagnosis and treatment of cancer |
| 06/19/2003 | WO2003050299A2 Method for analysing hereditary masculine infertility |
| 06/19/2003 | WO2003050298A1 Low molecular weight heparin assay, system and reagent therefor |
| 06/19/2003 | WO2003050297A1 Methods of screening for toxicity of test compounds |
| 06/19/2003 | WO2003050296A2 Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| 06/19/2003 | WO2003050294A2 Genotype analysis using human hair shaft |
| 06/19/2003 | WO2003050293A2 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 06/19/2003 | WO2003050290A2 Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics |
| 06/19/2003 | WO2003050289A2 Method for detecting microorganisms |
| 06/19/2003 | WO2003050287A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 06/19/2003 | WO2003050282A1 Mutated cyp2d6 genes |
| 06/19/2003 | WO2003050269A2 HIGH RESOLUTION TYPING SYSTEM FOR PATHOGENIC $i(E. COLI) |
| 06/19/2003 | WO2003050265A2 Compositions and methods for normalizing assays |
| 06/19/2003 | WO2003050264A2 Method for the analysis of differential gene expression |
| 06/19/2003 | WO2003050258A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 06/19/2003 | WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 06/19/2003 | WO2003050250A2 Chondrocyte precursors derived from human embryonic stem cells |
| 06/19/2003 | WO2003050248A2 Adenine nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 06/19/2003 | WO2003050243A2 Novel genes encoding colon cancer antigens |
| 06/19/2003 | WO2003050242A2 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 06/19/2003 | WO2003050236A2 Human genes and gene expression products isolated from human prostate |
| 06/19/2003 | WO2003050233A2 Gene promoters |
| 06/19/2003 | WO2003050137A2 Toll-like receptor 4 mutations |
| 06/19/2003 | WO2003050135A2 Use a parapox b2l protein to modify immune responses to administered antigens |
| 06/19/2003 | WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 06/19/2003 | WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |